Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Sitemap: |
Title | NEUPOGEN® (filgrastim) | Granulocyte Colony-Stimulating |
Description | NEUPOGEN (filgrastim) is approved for 5 indications in the following patient Learn about NEUPOGEN® (filgrastim), a daily injectable granulocyte colony-stimulating factor (GCS-F) available in two administration |
Keywords | N/A |
WebSite | neupogenhcp.com |
Host IP | 35.162.214.198 |
Location | United States |
Site | Rank |
US$19,797,732
Last updated: 2023-05-13 17:55:32
neupogenhcp.com has Semrush global rank of 534,622. neupogenhcp.com has an estimated worth of US$ 19,797,732, based on its estimated Ads revenue. neupogenhcp.com receives approximately 2,284,354 unique visitors each day. Its web server is located in United States, with IP address 35.162.214.198. According to SiteAdvisor, neupogenhcp.com is safe to visit. |
Purchase/Sale Value | US$19,797,732 |
Daily Ads Revenue | US$18,275 |
Monthly Ads Revenue | US$548,245 |
Yearly Ads Revenue | US$6,578,939 |
Daily Unique Visitors | 152,291 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
neupogenhcp.com. | A | 300 | IP: 35.162.214.198 |
neupogenhcp.com. | A | 300 | IP: 35.83.98.228 |
neupogenhcp.com. | NS | 86400 | NS Record: ns-1993.awsdns-57.co.uk. |
neupogenhcp.com. | NS | 86400 | NS Record: ns-327.awsdns-40.com. |
neupogenhcp.com. | NS | 86400 | NS Record: ns-545.awsdns-04.net. |
neupogenhcp.com. | NS | 86400 | NS Record: ns-1166.awsdns-17.org. |
neupogenhcp.com. | MX | 300 | MX Record: 3 amgen-com.mail.protection.outlook.com. |
Prescribing Information Important Safety Information Amgen MedInfo For Patients Indication-specific Dosing and Efficacy Back For the following patient populations: Chemotherapy-induced Febrile Neutropenia Acute Myeloid Leukemia Cancer Patients Undergoing Bone Marrow Transplantation Peripheral Blood Progenitor Cell Collection and Engraftment Severe Chronic Neutropenia Clinical Data Back Clinical Data Effect on Neutrophil Levels Neutrophil Recovery Duration of Therapy Administration Options About NEUPOGEN Back About NEUPOGEN How NEUPOGEN Works Daily Neutrophil Support Resources Back Resources Support Access and Reimbursement Amgen FIRST STEP ™ Co-pay Program For Patients Back For the following patient populations: Chemotherapy-induced<br><span style="white-space:nowrap;"> Febrile Neutropenia</span> Acute Myeloid Leukemia Cancer Patients Undergoing<br><span style="white-space:nowrap;">Bone Marrow Transplantation</span> <span |
HTTP/1.1 403 Forbidden Server: awselb/2.0 Date: Tue, 21 Dec 2021 20:59:07 GMT Content-Type: text/html Content-Length: 118 Connection: keep-alive |
Domain Name: NEUPOGENHCP.COM Registry Domain ID: 1766409596_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-11-12T10:12:03Z Creation Date: 2012-12-14T22:07:15Z Registry Expiry Date: 2022-12-14T22:07:15Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1166.AWSDNS-17.ORG Name Server: NS-1993.AWSDNS-57.CO.UK Name Server: NS-327.AWSDNS-40.COM Name Server: NS-545.AWSDNS-04.NET DNSSEC: unsigned >>> Last update of whois database: 2021-12-25T07:27:19Z <<< |